银杏素通过GPX4/OTUB1轴诱导铁死亡抑制三阴性乳腺癌细胞增殖与迁移

杨锋 ,  史伟 ,  王慧玲 ,  郑自通

中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (7) : 865 -874.

PDF (10190KB)
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (7) : 865 -874. DOI: 10.12092/j.issn.1009-2501.2026.07.001
基础研究

银杏素通过GPX4/OTUB1轴诱导铁死亡抑制三阴性乳腺癌细胞增殖与迁移

作者信息 +

Ginkgetin suppresses proliferation and migration of triple-negative breast cancer cells by inducing ferroptosis via the GPX4/OTUB1 axis

Author information +
文章历史 +
PDF (10434K)

摘要

目的: 观察银杏素对三阴性乳腺癌(TNBC)细胞铁死亡的影响,并探讨其通过调控GPX4/OTUB1轴发挥抗肿瘤作用的机制。方法: 将MDA-MB-231和MDA-MB-468细胞分为溶媒对照组(0.1% DMSO)、银杏素组(5、10、20 μmol/L)和联合干预组(20 μmol/L 银杏素+10 μmol/L Fer-1或20 μmol/L DFP)。采用CCK-8法检测细胞活力;EdU染色观察细胞增殖;集落形成实验评估细胞增殖能力;Transwell实验检测细胞迁移和侵袭;流式细胞术检测细胞内活性氧(ROS)、脂质过氧化和Fe2+水平;透射电镜(TEM)观察线粒体形态;Western blot检测GPX4、OTUB1等蛋白表达;免疫共沉淀分析GPX4与OTUB1的相互作用;免疫荧光观察GPX4和OTUB1的共定位。结果: CCK-8、EdU染色实验、集落形成实验和Transwell实验表明,银杏素处理可引起MDA-MB-231和MDA-MB-468细胞的增殖侵袭迁移能力显著降低,且呈剂量依赖性。铁死亡相关指标检测显示,银杏素处理组细胞内ROS水平、脂质过氧化产物和Fe2+含量显著升高(P<0.01),GSH水平显著降低(P<0.01),而铁死亡抑制剂Fer-1和DFP可部分逆转这些效应。铁死亡抑制剂对侵袭迁移的恢复效果也得到了证实。TEM观察到银杏素诱导的典型铁死亡线粒体形态改变。Western blot显示银杏素显著下调GPX4蛋白表达(P<0.01),促进其泛素化降解。免疫共沉淀证实银杏素抑制OTUB1与GPX4的相互作用(P<0.01)。结论: 银杏素可通过抑制OTUB1与GPX4的相互作用,促进GPX4泛素化降解,进而诱导铁死亡,发挥抗TNBC作用。

Abstract

AIM: To investigate the effects of Ginkgetin on ferroptosis in triple-negative breast cancer (TNBC) cells and explore its anti-tumor mechanism via regulating the GPX4/OTUB1 axis. METHODS: MDA-MB-231 and MDA-MB-468 cells were divided into vehicle control (0.1% DMSO), Ginkgetin treatment groups (5, 10, 20 μmol/L), and combination intervention groups (20 μmol/L Ginkgetin + 10 μmol/L Fer-1 or 20 μmol/L DFP). Cell viability was detected by CCK-8 assay; cell proliferation was assessed via EdU staining; colony formation assay was used to evaluate proliferative capacity; cell migration and invasion were measured by Transwell assay; intracellular reactive oxygen species (ROS), lipid peroxidation, and Fe2+ levels were quantified by flow cytometry; mitochondrial morphology was observed using transmission electron microscopy (TEM); protein expression (GPX4, OTUB1) was analyzed by Western blot; GPX4-OTUB1 interaction was studied by co-immunoprecipitation (Co-IP); and co-localization of GPX4 and OTUB1 was observed by immunofluorescence. RESULTS: CCK-8, EdU staining, colony formation assay, and Transwell assays demonstrated that Ginkgetin treatment significantly reduced the proliferation, invasion, and migration of MDA-MB-231 and MDA-MB-468 cells in a dose-dependent manner. Ferroptosis-related assays revealed that Ginkgetin-treated cells exhibited markedly increased intracellular ROS levels, lipid peroxidation products, and Fe2+ content (P<0.01), accompanied by significantly reduced glutathione (GSH) levels (P<0.01). These effects were partially reversed by ferroptosis inhibitors (Fer-1, DFP). Additionally, Fer-1 and DFP restored cell migration and invasion capabilities. TEM confirmed mitochondrial ultrastructural changes characteristic of ferroptosis. Western blot showed that Ginkgetin significantly downregulated GPX4 expression (P<0.01) and promoted its ubiquitination-dependent degradation. Co-IP confirmed that Ginkgetin inhibited the interaction between OTUB1 and GPX4 (P<0.01). CONCLUSION: Ginkgetin exerts anti-TNBC effects by inhibiting the OTUB1-GPX4 interaction, promoting GPX4 ubiquitination and degradation, and thereby inducing ferroptosis.

关键词

银杏素 / 三阴性乳腺癌 / 铁死亡 / 谷胱甘肽过氧化物酶4 / 去泛素化酶OTUB1

Key words

Ginkgetin / triple-negative breast cancer / ferroptosis / glutathione peroxidase 4 / deubiquitinase OTUB1

引用本文

引用格式 ▾
杨锋,史伟,王慧玲,郑自通. 银杏素通过GPX4/OTUB1轴诱导铁死亡抑制三阴性乳腺癌细胞增殖与迁移[J]. 中国临床药理学与治疗学, 2026, 31(7): 865-874 DOI:10.12092/j.issn.1009-2501.2026.07.001

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer[J].Annu Rev Pathol, 2022, 17: 181-204.

[2]

Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple negative breast cancer[J].BMJ, 2023, 381: e071674.

[3]

Li Y, Zhang H, Merkher Y, et al. Recent advances in therapeutic strategies for triple-negative breast cancer[J].J Hematol Oncol, 2022, 15(1): 121.

[4]

Liu Y, Wan Y, Jiang Y, et al. GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment[J].Biochim Biophys Acta Rev Cancer, 2023, 1878(3): 188890.

[5]

Karim AM, Eun Kwon J, Ali T, et al. Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies[J].Biochem Pharmacol, 2023, 212: 115545.

[6]

Zhang W, Liu Y, Liao Y, et al. GPX4, ferroptosis, and diseases[J].Biomed Pharmacother, 2024, 174: 116512.

[7]

Adnan M, Rasul A, Hussain G, et al. Ginkgetin: a natural biflavone with versatile pharmacological activities[J].Food Chem Toxicol, 2020, 145: 111642.

[8]

Liu Q, Chen L, Yin W, et al. Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis[J].Cell Cycle, 2022, 21(1): 74-85.

[9]

Yin L, Duan JJ, Bian XW, et al. Triple-negative breast cancer molecular subtyping and treatment progress[J].Breast Cancer Res, 2020, 22(1): 61.

[10]

Yang F, Xiao Y, Ding JH, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy[J].Cell Metab, 2023, 35(1): 84-100. e8.

[11]

Lorito N, Subbiani A, Smiriglia A, et al. FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer[J].EMBO Mol Med, 2024, 16(7): 1533-1559.

[12]

Lei M, Zhang YL, Huang FY, et al. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells[J].Sci Rep, 2023, 13(1): 21916.

[13]

Ding Y, Chen X, Liu C, et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells[J].J Hematol Oncol, 2021, 14(1): 19.

[14]

Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4[J].Free Radic Biol Med, 2020, 152: 175-185.

[15]

Dixon SJ, Pratt DA.Ferroptosis: a flexible constellation of related biochemical mechanisms[J].Mol Cell, 2023, 83(7): 1030-1042.

[16]

Li D, Wang Y, Dong C, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1[J].Oncogene, 2023, 42(2): 83-98.

[17]

Sukumar J, Gast K, Quiroga D, et al. Triple-negative breast cancer: promising prognostic biomarkers currently in development[J].Expert Rev Anticancer Ther, 2021, 21(2): 135-148.

基金资助

湖南省自然科学基金(2021JJ80015)

湖南省自然科学基金(2026JJ81320)

AI Summary AI Mindmap
PDF (10190KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉